1. Home
  2. PDS vs LXRX Comparison

PDS vs LXRX Comparison

Compare PDS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$93.00

Market Cap

1.1B

Sector

N/A

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.23

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
LXRX
Founded
1951
1995
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
PDS
LXRX
Price
$93.00
$2.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$122.33
$4.15
AVG Volume (30 Days)
95.2K
2.9M
Earning Date
04-29-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
$5.66
N/A
Revenue Next Year
$2.31
N/A
P/E Ratio
$884.15
N/A
Revenue Growth
N/A
60.24
52 Week Low
$53.45
$1.03
52 Week High
$103.80
$2.68

Technical Indicators

Market Signals
Indicator
PDS
LXRX
Relative Strength Index (RSI) 63.49 44.78
Support Level $86.74 $2.17
Resistance Level $92.51 $2.49
Average True Range (ATR) 2.56 0.09
MACD 0.55 -0.02
Stochastic Oscillator 87.37 18.03

Price Performance

Historical Comparison
PDS
LXRX

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: